Stuttgart, October 2024
Nanosync founder completes the EXIST Women programme
Twelve months of incubation with Stuttgart’s university founder centres turned a research question into the company that became Nanosync.
Ayimire Dilimulati, founder of Nanosync Biotech, has completed EXIST Women 2023–2024. The federally funded programme supports women in the phase before founding a company, and is delivered in the Stuttgart region by the founder centres of the University of Stuttgart, the University of Hohenheim and partner universities.
Over twelve months, participants receive support in four areas: mentoring and coaching, qualification and empowerment, exchange with other founders, and financial support. Dilimulati received her certificate of completion on 31 October 2024.
She used the programme to develop one question into a company: what would nutrition look like if it followed each person’s own biology, measured over time, rather than a population average?
“EXIST Women gave me the time and structure to turn a research question into a company.”Ayimire Dilimulati, founder of Nanosync
Nanosync is now developed as a start-up project at TTI GmbH in Stuttgart and is preparing to open early access to a small first group of users.
About Nanosync
Nanosync Biotech is a Stuttgart start-up developing personalised nutrition built from each person’s own blood data and renewed as they change. Nanosync is a start-up project at TTI GmbH. Press contact: info@nanosyncbiotech.com